Brain Tumor Reports
54

Volume 17 Number 3
March 2015


Home > Publications > Brain Tumor Reports > Volume 17, Year 2015 > Number 3, March


CONTENTS



BRAIN TUMORS
GLIOBLASTOMA
GLIOMAS
MEDULLOBLASTOMA
METASTATIC TUMORS





BRAIN TUMORS



Söderberg-Nauclér C, Johnsen JI.
Cytomegalovirus in human brain tumors: Role in pathogenesis and potential treatment options.
World J Exp Med. 2015 Feb 20;5(1):1-10. doi: 10.5493/wjem.v5.i1.1. eCollection 2015 Feb 20.
Source | Abstract | Full text | Similar articles





GLIOBLASTOMA



Coluccia D, Fandino J, Schwyzer L, O'Gorman R, Remonda L, Anon J, Martin E, Werner B.
First noninvasive thermal ablation of a brain tumor with MR-guided focused ultrasound.
J Ther Ultrasound. 2014 Oct 16;2:17. doi: 10.1186/2050-5736-2-17. eCollection 2014.
Source | Abstract | Full text | Similar articles




Dixit S, Hingorani M.
Comparative efficacy of bevacizumab and PCV chemotherapy in recurrent glioblastoma.
Clin Oncol (R Coll Radiol). 2015 Apr;27(4):246-7. doi: 10.1016/j.clon.2015.01.003. Epub 2015 Feb 3.
Source | Abstract | Full text | Similar articles




Hassler MR, Vedadinejad M, Flechl B, Haberler C, Preusser M, Hainfellner JA, Wöhrer A, Dieckmann KU, Rössler K, Kast R, Marosi C.
Response to imatinib as a function of target kinase expression in recurrent glioblastoma.
Springerplus. 2014 Feb 25;3:111. doi: 10.1186/2193-1801-3-111. eCollection 2014.
Source | Abstract | Full text | Similar articles




Kaloshi G, Diamandi P, Cakani B, Brace G, Rroji A, Petrela M.
The added value of bevacizumab concomitantly administered with carboplatin versus carboplatin alone in patients with recurrent glioblastomas.
Tumori. 2015 Jan-Feb;101(1):41-5. doi: 10.5301/tj.5000210. Epub 2015 Feb 11.
Source | Abstract | Full text | Similar articles




Lassen U, Chinot OL, McBain C, Mau-Sørensen M, Larsen VA, Barrie M, Roth P, Krieter O, Wang K, Habben K, Tessier J, Lahr A, Weller M.
Phase 1 dose-escalation study of the antiplacental growth factor monoclonal antibody RO5323441 combined with bevacizumab in patients with recurrent glioblastoma.
Neuro Oncol. 2015 Feb 9. pii: nov019. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Noh JH, Lee MH, Kim WS, Lim do H, Kim ST, Kong DS, Nam DH, Lee JI, Seol HJ.
Optimal treatment of leptomeningeal spread in glioblastoma: analysis of risk factors and outcome.
Acta Neurochir (Wien). 2015 Apr;157(4):569-76. doi: 10.1007/s00701-015-2344-5. Epub 2015 Feb 8.
Source | Abstract | Full text | Similar articles




Umeda K, Shibata H, Saida S, Hiramatsu H, Arakawa Y, Mizowaki T, Nishiuchi R, Adachi S, Heike T, Watanabe K.
Long-term efficacy of bevacizumab and irinotecan in recurrent pediatric glioblastoma.
Pediatr Int. 2015 Feb;57(1):169-71. doi: 10.1111/ped.12414.
Source | Abstract | Full text | Similar articles




van den Bent MJ, Gao Y, Kerkhof M, Kros JM, Gorlia T, van Zwieten K, Prince J, van Duinen S, Sillevis Smitt PA, Taphoorn M, French PJ.
Changes in the EGFR amplification and EGFRvIII expression between paired primary and recurrent glioblastomas.
Neuro Oncol. 2015 Feb 16. pii: nov013. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Wang M, Dignam JJ, Won M, Curran W, Mehta M, Gilbert MR.
Variation over time and interdependence between disease progression and death among patients with glioblastoma on RTOG 0525.
Neuro Oncol. 2015 Feb 16. pii: nov009. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Weller M, Tabatabai G, Kästner B, Felsberg J, Steinbach JP, Wick A, Schnell O, Hau P, Herrlinger U, Sabel MC, Wirsching HG, Ketter R, Bähr O, Platten M, Tonn JC, Schlegel U, Marosi C, Goldbrunner R, Stupp R, Homicsko K, Pichler J, Nikkhah G, Meixensberger J, Vajkoczy P, Kollias S, Hüsing J, Reifenberger G, Wick W; DIRECTOR Study Group.
MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial.
Clin Cancer Res. 2015 May 1;21(9):2057-64. doi: 10.1158/1078-0432.CCR-14-2737. Epub 2015 Feb 5.
Source | Abstract | Full text | Similar articles





GLIOMAS



Peruzzi L, Iuvone L, Ruggiero A, Colosimo C, Stefanini MC, Riccardi R.
Neuropsychological Deterioration Predicts Tumor Progression in a Young Boy With Bithalamic Glioma.
Appl Neuropsychol Child. 2015 Feb 4:1-6. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




HIGH-GRADE GLIOMAS


Chowdhary SA, Ryken T, Newton HB.
Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis.Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis.
J Neurooncol. 2015 Apr;122(2):367-82. doi: 10.1007/s11060-015-1724-2. Epub 2015 Jan 29.
Source | Abstract | Full text | Similar articles




Hervey-Jumper SL, Berger MS.
In reply: Reoperation for recurrent high-grade glioma: does tumor genetics play a role?
Neurosurgery. 2015 Apr;76(4):E497. doi: 10.1227/NEU.0000000000000667.
Source | Abstract | Full text | Similar articles




Minniti G, Agolli L, Falco T, Scaringi C, Lanzetta G, Caporello P, Osti MF, Esposito V, Enrici RM.
Hypofractionated stereotactic radiotherapy in combination with bevacizumab or fotemustine for patients with progressive malignant gliomas.
J Neurooncol. 2015 May;122(3):559-66. doi: 10.1007/s11060-015-1745-x. Epub 2015 Feb 22.
Source | Abstract | Full text | Similar articles





MEDULLOBLASTOMA



Bai RY, Staedtke V, Rudin CM, Bunz F, Riggins GJ.
Effective treatment of diverse medulloblastoma models with mebendazole and its impact on tumor angiogenesis.
Neuro Oncol. 2015 Apr;17(4):545-54. doi: 10.1093/neuonc/nou234. Epub 2014 Sep 24.
Source | Abstract | Full text | Similar articles




Bodhinayake I, Symons M, Boockvar JA.
Repurposing mebendazole for the treatment of medulloblastoma.
Neurosurgery. 2015 Feb;76(2):N15-6. doi: 10.1227/01.neu.0000460594.93803.cb.
Source | Abstract | Full text | Similar articles




Pöschl J, Koch A, Schüller U.
Histological subtype of medulloblastoma frequently changes upon recurrence.
Acta Neuropathol. 2015 Mar;129(3):459-61. doi: 10.1007/s00401-015-1397-0. Epub 2015 Feb 8.
Source | Abstract | Full text | Similar articles





METASTATIC TUMORS



Costa DB, Shaw AT, Ou SH, Solomon BJ, Riely GJ, Ahn MJ, Zhou C, Shreeve SM, Selaru P, Polli A, Schnell P, Wilner KD, Wiltshire R, Camidge DR, Crinò L.
Clinical Experience With Crizotinib in Patients With Advanced ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastases.
J Clin Oncol. 2015 Jun 10;33(17):1881-8. doi: 10.1200/JCO.2014.59.0539. Epub 2015 Jan 26.
Source | Abstract | Full text | Similar articles




Mehta MP, Wang D, Wang F, Kleinberg L, Brade A, Robins HI, Turaka A, Leahy T, Medina D, Xiong H, Mostafa NM, Dunbar M, Zhu M, Qian J, Holen K, Giranda V, Curran WJ.
Veliparib in combination with whole brain radiation therapy in patients with brain metastases: results of a phase 1 study.
J Neurooncol. 2015 Apr;122(2):409-17. doi: 10.1007/s11060-015-1733-1. Epub 2015 Feb 15.
Source | Abstract | Full text | Similar articles




Schowinsky JT, Ormond DR, Kleinschmidt-DeMasters BK.
Tibial adamantinoma: late metastasis to the brain.
J Neuropathol Exp Neurol. 2015 Jan ;74(1):95-7. doi: 10.1097/NEN.0000000000000145. Epub 2015 Jan 1.
Source | Abstract | Full text | Similar articles




Taylor DR, Weaver JA.
Tumor pseudoprogression of spinal metastasis after radiosurgery: a novel concept and case reports.
J Neurosurg Spine. 2015 May;22(5):534-9. doi: 10.3171/2014.10.SPINE14444. Epub 2015 Feb 6.
Source | Abstract | Full text | Similar articles